glp 1 agonists moa GLP-1 Receptor as Treatments for Type 2 Diabetes GLP1 Receptor Agonists—Effects beyond Obesity

Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO) Please refer to the solubility information to select the appropriate solvent

[DOI] [PubMed] [Google Scholar] 96

J Clin Invest 1993;91:3017.ArticlePubMedPMC 56

The mean relative change from baseline in liver fat at 24 weeks was 42.9% (1 mg), 57.0% (4 mg), 81.4% (8 mg), 82.4% (12 mg), and +0.3% (placebo)

Uveitis: Inflammation of the middle layer of the eye (uvea) can cause floaters

Expert testimony can be compelling in these types of cases, helping to shape the plaintiffs arguments or refute the drug companys claims